Introducing a pneumococcal vaccine to an existing influenza immunization program: Vaccination rates and predictors of noncompliance

被引:47
作者
Opstelten, W [1 ]
Hak, E [1 ]
Verheij, TJM [1 ]
van Essen, GA [1 ]
机构
[1] Univ Utrecht, Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, NL-3508 AB Utrecht, Netherlands
关键词
D O I
10.1016/S0002-9343(01)00880-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Influenza vaccination has been recommended for all elderly people in The Netherlands since 1996, with greater than 80% compliance. It is unknown, however, if the addition of another vaccine to this immunization program will affect compliance. SUBJECTS AND METHODS: General practitioners offered a pneumococcal vaccine together with the yearly influenza vaccination to 3365 patients aged 65 years and older. A questionnaire was then mailed to a stratified sample (n = 972) of these patients. Factors associated with noncompliance with vaccination were assessed using polytomous logistic regression. RESULTS: A total of 2529 patients (75%) received the pneumococcal vaccine and 2812 (84%) received the influenza vaccine. Predictors of noncompliance with the pneumococcal vaccine were perceived lack of recommendation by the general practitioner (odds ratio [OR] = 4.6; 95% confidence interval [CI], 2.6 to 8.3) and fear of local side effects (OR = 2.8; 95% CI, 1.6 to 4.6). Predictors of noncompliance with both vaccinations also included unwillingness to comply with the doctor's advice (OR = 6.1; 95% Cl, 2.4 to 15.4), the belief that vaccinations weaken one's natural defenses (OR = 2.7; 95% Cl, 1.4 to 5.3) or that influenza is not dangerous (OR = 2.9; 95% Cl, 1.5 to 5.4), and the fear of becoming sick from pneumococcal vaccination (OR = 2.9; 95% Cl, 1.1 to 7.9). People who felt healthy found it difficult to visit the doctor's office, had private medical insurance, or were younger than 75 years of age also had a greater risk of not being vaccinated. CONCLUSION: Introducing a pneumococcal vaccine to an existing influenza immunization program resulted in high pneumococcal and influenza vaccination rates. A wider diversity of patient characteristics and attitudes was present when neither vaccination was received. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 27 条
[1]  
BROOME CV, 1981, REV INFECT DIS, V3, pS82
[2]   Influenza and pneumococcal vaccination among Native American elders in a primary care practice [J].
Buchwald, D ;
Sheffield, J ;
Furman, R ;
Hartman, S ;
Dudden, M ;
Manson, S .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) :1443-1448
[3]   PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY - AN EVALUATION OF CURRENT RECOMMENDATIONS [J].
BUTLER, JC ;
BREIMAN, RF ;
CAMPBELL, JF ;
LIPMAN, HB ;
BROOME, CV ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (15) :1826-1831
[4]  
*CDCP, 1999, MMWR-MORBID MORTAL W, V48, P86
[5]  
Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P657
[6]   PREVENTING PNEUMOCOCCAL BACTEREMIA IN PATIENTS AT RISK - RESULTS OF A MATCHED CASE-CONTROL STUDY [J].
FARR, BM ;
JOHNSTON, BL ;
COBB, DK ;
FISCH, MJ ;
GERMANSON, TP ;
ADAL, KA ;
ANGLIM, AM .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (21) :2336-2340
[7]   Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease [J].
Fletcher, TJ ;
Tunnicliffe, WS ;
Hammond, K ;
Roberts, K ;
Ayres, JG .
BRITISH MEDICAL JOURNAL, 1997, 314 (7095) :1663-1665
[8]  
*GEZ, 1982, ADV INZ PNEUM IMM
[9]   Pneumococcal vaccination of the elderly: Do we need another trial? [J].
Hak, E ;
Grobbee, DE ;
van Essen, GA ;
Buskens, E ;
Verheij, TJM .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (11) :1698-1699
[10]  
Hak E, 2000, SCAND J PRIM HEALTH, V18, P237